BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23563127)

  • 1. Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction.
    Kim MS; Kato TS; Farr M; Wu C; Givens RC; Collado E; Mancini DM; Schulze PC
    J Am Coll Cardiol; 2013 Jun; 61(22):2253-2261. PubMed ID: 23563127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model of End-Stage Liver Disease-eXcluding International Normalized Ratio (MELD-XI) Scoring System to Predict Outcomes in Patients Who Undergo Left Ventricular Assist Device Implantation.
    Critsinelis A; Kurihara C; Volkovicher N; Kawabori M; Sugiura T; Manon M; Wang S; Civitello AB; Morgan JA
    Ann Thorac Surg; 2018 Aug; 106(2):513-519. PubMed ID: 29626453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of liver biopsy with MELD-XI scores for post-transplant outcome prediction in patients with advanced heart failure and suspected liver dysfunction.
    Farr M; Mitchell J; Lippel M; Kato TS; Jin Z; Ippolito P; Dove L; Jorde UP; Takayama H; Emond J; Naka Y; Mancini D; Lefkowitch JH; Schulze PC
    J Heart Lung Transplant; 2015 Jul; 34(7):873-82. PubMed ID: 25851466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery.
    Assenza GE; Graham DA; Landzberg MJ; Valente AM; Singh MN; Bashir A; Fernandes S; Mortele KJ; Ukomadu C; Volpe M; Wu F
    Heart; 2013 Apr; 99(7):491-6. PubMed ID: 23406689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Value of the Model for End-Stage Liver Disease Score Excluding International Normalized Ratio One Year After Orthotopic Heart Transplantation.
    Szyguła-Jurkiewicz B; Zakliczyński M; Szczurek W; Nadziakiewicz P; Gąsior M; Zembala M
    Transplant Proc; 2016 Jun; 48(5):1703-7. PubMed ID: 27496475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Value of Hepatic and Renal Dysfunction Based on the Models for End-Stage Liver Disease in Patients With Heart Failure Evaluated for Heart Transplant.
    Szyguła-Jurkiewicz B; Nadziakiewicz P; Zakliczynski M; Szczurek W; Chraponski J; Zembala M; Gasior M
    Transplant Proc; 2016 Jun; 48(5):1756-60. PubMed ID: 27496486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified Model for End-Stage Liver Disease eXcluding INR (MELD-XI) Score Predicts Early Death After Pediatric Heart Transplantation.
    Grimm JC; Magruder JT; Do N; Spinner JA; Dungan SP; Kilic A; Patel N; Nelson KL; Jacobs ML; Cameron DE; Vricella LA
    Ann Thorac Surg; 2016 Feb; 101(2):730-5. PubMed ID: 26347119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver dysfunction assessed by model for end-stage liver disease excluding INR (MELD-XI) scoring system predicts adverse prognosis in heart failure.
    Abe S; Yoshihisa A; Takiguchi M; Shimizu T; Nakamura Y; Yamauchi H; Iwaya S; Owada T; Miyata M; Sato T; Suzuki S; Oikawa M; Kobayashi A; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh S; Takeishi Y
    PLoS One; 2014; 9(6):e100618. PubMed ID: 24955578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system.
    Yang JA; Kato TS; Shulman BP; Takayama H; Farr M; Jorde UP; Mancini DM; Naka Y; Schulze PC
    J Heart Lung Transplant; 2012 Jun; 31(6):601-10. PubMed ID: 22458997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.
    Kim WR; Mannalithara A; Heimbach JK; Kamath PS; Asrani SK; Biggins SW; Wood NL; Gentry SE; Kwong AJ
    Gastroenterology; 2021 Dec; 161(6):1887-1895.e4. PubMed ID: 34481845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired hepato-renal function defined by the MELD XI score as prognosticator in acute heart failure.
    Biegus J; Zymliński R; Sokolski M; Siwołowski P; Gajewski P; Nawrocka-Millward S; Poniewierka E; Jankowska EA; Banasiak W; Ponikowski P
    Eur J Heart Fail; 2016 Dec; 18(12):1518-1521. PubMed ID: 27709804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model for End-Stage Liver Disease Excluding INR (MELD-XI) score is associated with hemodynamic impairment and predicts mortality in critically ill patients.
    Wernly B; Lichtenauer M; Vellinga N; Boerma C; Ince C; Kelm M; Jung C
    Eur J Intern Med; 2018 May; 51():80-84. PubMed ID: 29572092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of the modified model for end-stage liver disease (MELD) score including albumin in acute heart failure.
    Liao S; Lu X; Cheang I; Zhu X; Yin T; Yao W; Zhang H; Li X
    BMC Cardiovasc Disord; 2021 Mar; 21(1):128. PubMed ID: 33750318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart Transplant and Hepato-Renal Dysfunction: The Model of End-Stage Liver Disease Excluding International Normalized Ratio as a Predictor of Postoperative Outcomes.
    Loforte A; Fiorentino M; Gliozzi G; Mariani C; Folesani G; Suarez SM; Russo A; Masetti M; Potena L; Pacini D
    Transplant Proc; 2019 Nov; 51(9):2962-2966. PubMed ID: 31607616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposing a Sex-Adjusted Sodium-Adjusted MELD Score for Liver Transplant Allocation.
    Sealock JM; Ziogas IA; Zhao Z; Ye F; Alexopoulos SP; Matsuoka L; Chen G; Davis LK
    JAMA Surg; 2022 Jul; 157(7):618-626. PubMed ID: 35583884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Hepatorenal Function By Modified Model for End-stage Liver Disease (MELD) Score in Patients Undergoing Tricuspid Annuloplasty.
    Chen Y; Liu YX; Seto WK; Wu MZ; Yu YJ; Lam YM; Au WK; Chan D; Sit KY; Ho LM; Tse HF; Yiu KH
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30006492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic value of the model for end-stage liver disease combined with serum sodium levels in patients with decompensated cirrhosis].
    Li JY; Deng Q; Wang Y; Xu MY; Lu LG
    Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):896-901. PubMed ID: 23522249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of liver dysfunction assessed by MELD-XI scoring system in patients undergoing transcatheter aortic valve implantation.
    Arai T; Yashima F; Yanagisawa R; Tanaka M; Shimizu H; Fukuda K; Watanabe Y; Naganuma T; Araki M; Tada N; Yamanaka F; Shirai S; Yamamoto M; Hayashida K;
    Int J Cardiol; 2017 Feb; 228():648-653. PubMed ID: 27883976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model for End-stage Liver Disease excluding INR (MELD-XI) score in critically ill patients: Easily available and of prognostic relevance.
    Wernly B; Lichtenauer M; Franz M; Kabisch B; Muessig J; Masyuk M; Hoppe UC; Kelm M; Jung C
    PLoS One; 2017; 12(2):e0170987. PubMed ID: 28151948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction.
    Chokshi A; Cheema FH; Schaefle KJ; Jiang J; Collado E; Shahzad K; Khawaja T; Farr M; Takayama H; Naka Y; Mancini DM; Schulze PC
    J Heart Lung Transplant; 2012 Jun; 31(6):591-600. PubMed ID: 22458996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.